SCHEMBL51252

SCHEMBL51252

CCN(CC)c1ccc(/C=C2/CC/C(=C\c3ccc(N(CC)CC)cc3)C2=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.58
ALDH1A1 P00352 6/20 0.56
ALDH3A1 P30838 1/20 0.56
ALDH1A3 P47895 1/20 0.56
MEN1 O00255 8/20 0.55
KMT2A Q03164 8/20 0.55
LMNA P02545 5/20 0.55
MAPT P10636 5/20 0.55
MAPK1 P28482 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MCOLN3 Q8TDD5 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
FGFR1 P11362 1/20 0.55
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
HSD11B1 P28845 1/20 0.53
GSK3B P49841 1/20 0.53
BCHE P06276 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2847156 1.00 CYP1A2 (0.58) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL51253 1.00 CYP1A2 (0.58) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL29099922 1.00 CYP1A2 (0.58) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL352162 0.93 CYP1A2 (0.69) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL352161 0.93 CYP1A2 (0.69) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL6270129 0.90 FGFR1 (0.51) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL6270133 0.90 FGFR1 (0.51) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL8780610 0.87 ALDH1A1 (0.53) CYP1A2ALDH1A1ALDH3A1ALDH1A3MEN1
SCHEMBL9804016 0.84 MIF (0.67) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL30298451 0.84 MIF (0.67) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382868-B2 Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same ICURE PHARMACEUTICAL INC. (KR) 2022-07-12 US claimed
US-20190046463-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME ICURE PHARMACEUTICAL INC. (KR) 2019-02-14 US claimed
EP-3415141-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME Icure Pharmaceutical Inc. (KR) 2018-12-19 EP claimed
US-8399176-B2 Photosensitive resin composition LG CHEM, LTD. (KR) 2013-03-19 US claimed
US-20100216073-A1 PHOTOSENSITIVE RESIN COMPOSITION LG CHEM, LTD. (KR) 2010-08-26 US claimed
US-20070148556-A1 Photosensitive composition for volume hologram recording DAI NIPPON PRINTING CO., LTD. (JP) 2007-06-28 US claimed
US-4415621-A COATING A SUBSTRATE WITH AN AMORPHOUS BINDER AND DYE; TELEVISION; DISCS; ABSORPTION EASTMAN KODAK COMPANY (US) 1983-11-15 US claimed
EP-4291953-B1 IMPROVED BLEACHING XETOS AG (DE) 2026-04-15 EP disclosed
US-20260022199-A1 HOLOGRAPHIC PHOTOPOLYMER MATERIAL, HOLOGRAPHIC PHOTOSENSITIVE FILM, HOLOGRAPHIC OPTICAL ELEMENT, AND DISPLAY DEVICE HUAWEI TECH CO LTD (CN) 2026-01-22 US disclosed
US-12516211-B2 Ink composition and electronic device including film formed using the ink composition SAMSUNG DISPLAY CO., LTD. (KR) 2026-01-06 US disclosed
EP-4668017-A1 HOLOGRAPHIC PHOTOPOLYMERIZABLE MATERIAL, HOLOGRAPHIC PHOTOSENSITIVE FILM, HOLOGRAPHIC OPTICAL ELEMENT, AND DISPLAY DEVICE Huawei Technologies Co., Ltd. (CN) 2025-12-24 EP disclosed
EP-4291587-B1 PHOTOPOLYMERIZABLE HOE COMPOSITION XETOS AG (DE) 2025-11-12 EP disclosed
US-12441840-B2 Compound, binder resin, negative-type photosensitive resin composition, and display device comprising black bank formed using same LG CHEM, LTD. (KR) 2025-10-14 US disclosed
EP-0042307-B1 AN OPTICAL RECORDING ELEMENT AND A METHOD OF RECORDING INFORMATION USING THE ELEMENT EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-09-10 EP disclosed
US-4499165-A COMPATABILITY; STABILITY; LASERS; DATA PROCESSING EASTMAN KODAK COMPANY (US) 1985-02-12 US disclosed
EP-0118881-A2 Binder-mixtures for optical recording layers and elements EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-09-19 EP disclosed
US-4415621-A COATING A SUBSTRATE WITH AN AMORPHOUS BINDER AND DYE; TELEVISION; DISCS; ABSORPTION EASTMAN KODAK COMPANY (US) 1983-11-15 US disclosed
US-4340655-A Thermal and mechanical barrier layers for optical recording elements EASTMAN KODAK COMPANY (US) 1982-07-20 US disclosed
US-4335173-A Method and means for reducing undesirable effects of dirt particles on a flexible record device EASTMAN KODAK COMPANY (US) 1982-06-15 US disclosed
EP-0042307-A2 An optical recording element and a method of recording information using the element EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1981-12-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022199-A1 HOLOGRAPHIC PHOTOPOLYMER MATERIAL, HOLOGRAPHIC PHOTOSENSITIVE FILM, HOLOGRAPHIC OPTICAL ELEMENT, AND DISPLAY DEVICE VCL, MACF1, FGB CYP1A2 2166/4885ALDH1A1 1820/4885ALDH3A1 1877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.